Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5RDC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,057
Award facts
- Contract value 100% obligated
- $16,056.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,056.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on January 30, 2026, with an ultimate completion date of February 2, 2026. This delivery order represents a non-competitive child contract issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic drugs, vaccines, specialty medications, and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The company's contract award demonstrates its capability to fulfill federal medical supply requirements through its established parent company relationship with Cencora, Inc., which consistently supplies diverse pharmaceutical products across multiple therapeutic domains including diabetes medications, neurological treatments, and pain management pharmaceuticals. This delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in providing essential prescription medications to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5RDC?
SPE2DR26F5RDC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F5RDC worth?
The government has obligated $16,057 on SPE2DR26F5RDC.
Is contract SPE2DR26F5RDC an order under another contract?
Yes. SPE2DR26F5RDC is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RDC competed?
The extent of competition for SPE2DR26F5RDC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award